Risperdal TV commercial advertisements are airing on stations across the U.S., urging individuals who developed male breasts to consider a lawsuit against its manufacturer. With more and more plaintiffs continuing to come forward after seeing these solicitations, it’s clear that this side effect, which is known as gynecomastia, is far from uncommon.
If a Risperdal lawsuit commercial has you considering a claim against its manufacturers, Johnson & Johnson and Janssen Pharmaceuticals, Inc., the time is now to take action. The attorneys at Bernstein Liebhard LLP are speaking on a regular basis with men who developed gynecomastia, which has resulted in their having to undergo liposuction or a mastectomy to alleviate this painful and embarrassing condition. Call our Firm to speak with attorney who can walk you through the legal process of filing a Risperdal lawsuit at .
As the controversy surrounding Risperdal continues to mount, it is hardly a coincidence that the number of law firms airing lawsuit commercials has continued to increase. In November 2013, Johnson & Johnson and Janssen agreed to a $2.2 billion settlement with the U.S. Department of Justice that resolved claims that the companies promoted Risperdal and other products off-label to treat elderly patients with dementia and children, before it received federal approval for pediatric uses in 2006. The companies were also accused of concealing the antipsychotic drug’s association with gynecomastia and other risks.
According to Risperdal lawsuit commercials, individuals currently suffering from gynecomastia may experience the following breast-related symptoms:
In some cases, gynecomastia complications stemming from Risperdal use have resulted in breast sizes as large as D cups.
Commercials you may have seen involving Risperdal indicate that over 600 claims involving the medication have been centralized in a consolidated litigation underway in the Philadelphia Court of Common Pleas. Many of the cases filed in Pennsylvania involve men who suffered gynecomastia-related complications.
A number of Risperdal TV commercials note a study published in 2006 in the Journal of Clinical Psychopharmacology, in which researchers found that gynecomastia side effects from this medication may be caused by its potential to elevate levels of prolactin, a hormone associated with lactation in young mothers and breast development in girls. Research released in a 2009 issue of the Journal of Child and Adolescent Pharmacology found that prolactin levels may remain elevated for up to two years.
Risperdal is an atypical antipsychotic medication approved to treat schizophrenia and bipolar disorder in adults and adolescents, as well as irritability in children ages 6-to-16 with autistic disorder. The medication is also frequently used as a treatment for ADHD, even though it has not been explicitly approved for this use by the FDA.
You’ve seen the Risperdal TV commercial ads; now it is time to file a lawsuit. The nationwide law firm of Bernstein Liebhard LLP is actively filing cases on behalf of individuals who experienced the following:
If any or several of these problems sound familiar, call the Firm’s attorneys to learn if you are eligible to file a lawsuit: .